Subdural Hematoma During Lorlatinib-Induced Regression of Leptomeningeal Carcinomatosis with Suspected Dural Involvement in ALK-Positive Lung Adenocarcinoma. (PubMed, Intern Med) - Oct 8, 2026 - "The hematoma resolved without surgery and did not recur during the 6 years of treatment. SDH may occur during the rapid regression of leptomeningeal disease with suspected dural involvement under CNS-penetrant ALK inhibitor therapy."
Journal • Brain Cancer • CNS Disorders • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • ALK
|
|
Jun Nishiyama; Kaiki Suzuki; Katsuyoshi Tomomatsu; Kohei Umemoto; Koichiro Asano; Naoki Hayama; Taiyo Kakefuda; Tsuyoshi Oguma; Yoko Ito; Yukihiro Horio
|